Barclays raised the firm’s price target on Procter & Gamble to $168 from $165 and keeps an Overweight rating on the shares ahead of the Q1 report. In consumer health products and beverages, investors are starting to look beyond the expensive high-visibility names for more value-oriented opportunities, the analyst tells investors in a research note. Meanwhile, in food, the firm wouldn’t be surprised to see more “second derivative” share reactions to Q1 upside versus “admittedly very subdued expectations.”
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PG:
- Angela Braly Retires from Procter & Gamble Board
- Procter & Gamble’s Strategic Moves Impacting Stock Market
- Procter & Gamble raises quarterly dividend by 7% to $1.01 per share
- Procter & Gamble recalls 8.2M defective bags of Tide, Gain, Ace, Ariel Pods
- Procter & Gamble price target raised to $172 from $170 at Deutsche Bank